Evidence map›Paper›PMID 29988567›Full record

ArticleFEBS open bio2018

Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1.

Daisuke Tanokashira, Eiko Kurata, Wataru Fukuokaya, Kenshiro Kawabe, Mana Kashiwada, Hideyuki Takeuchi, Masamitsu Nakazato, Akiko Taguchi

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daisuke TanokashiraDepartment of Integrative Aging Neuroscience National Center for Geriatrics and Gerontology Obu Japan.
Eiko KurataDepartment of Neurology, Respirology, Endocrinology and Metabolism Miyazaki University School of Medicine Japan.
Wataru FukuokayaDepartment of Neurology, Respirology, Endocrinology and Metabolism Miyazaki University School of Medicine Japan.
Kenshiro KawabeDepartment of Neurology, Respirology, Endocrinology and Metabolism Miyazaki University School of Medicine Japan.
Mana KashiwadaDepartment of Integrative Aging Neuroscience National Center for Geriatrics and Gerontology Obu Japan.
Hideyuki TakeuchiDepartment of Neurology and Stroke Medicine Yokohama City University Graduate School of Medicine Japan.
Masamitsu NakazatoDepartment of Neurology, Respirology, Endocrinology and Metabolism Miyazaki University School of Medicine Japan.
Akiko TaguchiDepartment of Integrative Aging Neuroscience National Center for Geriatrics and Gerontology Obu Japan.
University of Miyazaki · JPNational Center for Geriatrics and Gerontology · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related reduction in adult hippocampal neurogenesis is correlated with cognitive impairment. Diabetes is a chronic systemic disease that negatively affects adult neural stem cells and memory functions in the hippocampus. Despite growing concern regarding the potential role of diabetic drugs in neural abnormalities, their effects on progressive deterioration of neurogenesis and cognitive functions remain unknown. Here, we show that the combination of aging and diabetes in mice causes a marked decrease in hippocampal neurogenesis along with memory impairment and elevated neuroinflammation. Prolonged treatment with metformin, a biguanide antidiabetic medication, promotes cell proliferation and neuronal differentiation and inhibits aging- and diabetes-associated microglial activation, which is related to homeostatic neurogenesis, leading to enhanced hippocampal neurogenesis in middle-aged diabetic mice. Although chronic therapy with metformin fails to achieve recovery from hyperglycemia, a key feature of diabetes in middle-aged diabetic mice, it improves hippocampal-dependent spatial memory functions accompanied by increased phosphorylation of adenosine monophosphate-activated protein kinase (AMPK), atypical protein kinase C ζ (aPKC ζ), and insulin receptor substrate 1 (IRS1) at selective serine residues in the hippocampus. Our findings suggest that signaling networks acting through long-term metformin-stimulated phosphorylation of AMPK, aPKC ζ/λ, and IRS1 serine sites contribute to neuroprotective effects on hippocampal neurogenesis and cognitive function independent of a hypoglycemic effect.

Indexed as

dementiadiabetesdiabetic drugsdrug repositioningIRS1 serine phosphorylationmemory function

Identifiers

PMID29988567
PMCPMC6026705
OpenAlexW2800530336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.